Pregled bibliografske jedinice broj: 76334
CYP2D6 polymorphism in patients with head and neck cancer
CYP2D6 polymorphism in patients with head and neck cancer // 7th Alps-Adria Congress, Abstracts / Congress Secretariat (ur.).
Regensburg: Congress Secretariat, 2002. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 76334 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
CYP2D6 polymorphism in patients with head and neck cancer
Autori
Štefanovic, Mario ; Begonja, Antonija ; Topić, Elizabeta ; Čurčić, Ivica ; Šimundić, Ana-Maria
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
7th Alps-Adria Congress, Abstracts
/ Congress Secretariat - Regensburg : Congress Secretariat, 2002
Skup
7th Alps-Adria Congress International Congress for Clinical Chemistry and Laboratory Medicine
Mjesto i datum
Regensburg, Njemačka, 20.04.2002. - 22.04.2002
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
CYP2D6; head and neck cancer
Sažetak
We investigated the association of drug metabolizing enzyme system CYP P450 CYP2D6 null alleles (CYP2D6*3, *4, *5, *6, *7, and *8) with incidence of tumors in patients having head and neck cancer (HNC). It is known that persons bearing two null alleles poorly metabolize some common drugs (Poor Metabolizer phenotype PM) as well as other xenobiotic and carcinogenic substances. Persons with only one disrupted CYP2D6 gene (bearing one normal and one null allele) are considered to be Intermediate Metabolizer phenotype (IM). We genotyped 145 controls, and 67 HNC patients by Multiplex Allele Specific PCR on whole blood DNA. Study results showed allelic frequencies for *3, *4 and *6 alleles (only alleles observed) in controls to be 1.4%, 11.0% and 1.0%, respectively; among them we found 2.1% PMs and 22.8% IMs. In cancer patients group allelic frequencies for *3, *4 and *6 were 1.5%, 19.4% and 3,7% respectively, and no other alleles were found; among them we found 3.0% PMs and 43.3% IMs. Our study results showed statistically significant difference for genotype frequencies (Chi-square; p=0.025) as well as predicted phenotype frequencies (Chi-square; p=0.034). IM phenotype showed to be responsible for increased risk to HNC (Odds ratio 2.6; 95%CI= 1.248 - 5.193). To confirm our preliminary findings, we plan to study larger group of patients.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
134003
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Mario Štefanović
(autor)
Ivica Čurčić
(autor)
Antonija Jurak Begonja
(autor)
Elizabeta Topić
(autor)
Ana-Maria Šimundić
(autor)